Delgocitinib cream had superior efficacy and a better safety profile compared with oral alitretinoin for the treatment of ...

The Chronic Hand Eczema market growth is driven by factors like increase in the prevalence of Chronic Hand Eczema, ...

Dermatology providers reported strong impacts on the work and home life of patients with moderate to severe chronic hand eczema, a manifestation of atopic dermatitis.

More than 90% of dermatology clinicians surveyed by Leo Pharma say their patients with moderate to severe chronic hand eczema ...

Delgocitinib cream is efficacious and well-tolerated for the treatment of adults with chronic hand eczema for up to 52 weeks.

DELTA FORCE is the first head-to-head phase 3 trial comparing a systemic and investigational delgocitinib topical treatment for Chronic Hand Eczema (CHE). 1 The publication summarizes the results ...

2 There is currently no FDA-approved treatment for CHE. “Given that we use our hands for almost everything we do, chronic hand eczema can significantly disrupt patients' daily routines,” said ...